Yoshida M, Uchimura A, Kiso M, Hasegawa A
Department of Applied Bioorganic Chemistry, Gifu University, Japan.
Glycoconj J. 1993 Feb;10(1):3-15. doi: 10.1007/BF00731181.
Sialyl Lewis X ganglioside analogues containing 5-acetamido-3,5-dideoxy-L-arabino-2-heptulopyranosylonic acid (C7-Neu5Ac), 5-acetamido-3,5-dideoxy-D-galacto-2-octulopyranosylonic acid (C8-Neu5Ac), and 5-acetamido-3,5-dideoxy-L-glycero-D-galacto-1-2-nonulopyranosylonic++ + acid (8-epi-Neu5Ac) in place of N-acetylneuraminic acid (Neu5Ac) have been synthesized. Glycosylation of 2-(trimethylsilyl)ethyl 6-O-benzoyl-beta-D-galactopyranoside with the phenyl or methyl 2-thioglycoside derivatives of the respective sialic acids, using N-iodosuccinimide (NIS)-trifluoromethanesulfonic acid as a promoter in acetonitrile, gave the three required 2-(trimethylsilyl)ethyl (2S)-sialyl-(2-->3)-beta-galactopyranosides. These were converted via O-benzoylation, selective transformation of the 2-(trimethylsilyl)ethyl group to acetyl, and introduction of the methylthio group with methylthiotrimethylsilane into the corresponding glycosyl donors. Glycosylation of 2-(trimethylsilyl)ethyl O-(2,3,4-tri-O-benzyl-alpha-L-fucopyranosyl)-(1-->3)-O-(2-acetamido-6-O- benzyl- 2-deoxy-beta-D-glucopyranosyl)-(1-->3)-2,4,6-tri-O-benzyl-beta-D- galactopyranoside with these donors in the presence of dimethyl(methylthio)sulfonium triflate (DMTST) afforded the expected beta-glycosides, which were converted into the corresponding alpha-trichloroacetimidates, and these, on coupling with (2S, 3R, 4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the required beta-glycosides. Finally, these were transformed via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation, and de-esterification into the target compounds in good yields.
已经合成了含有5-乙酰氨基-3,5-二脱氧-L-阿拉伯糖-2-庚酮糖醛酸(C7-Neu5Ac)、5-乙酰氨基-3,5-二脱氧-D-半乳糖-2-辛酮糖醛酸(C8-Neu5Ac)和5-乙酰氨基-3,5-二脱氧-L-甘油-D-半乳糖-1,2-壬酮糖醛酸(8-表-Neu5Ac)以取代N-乙酰神经氨酸(Neu5Ac)的唾液酸Lewis X神经节苷脂类似物。在乙腈中使用N-碘代琥珀酰亚胺(NIS)-三氟甲磺酸作为促进剂,使2-(三甲基甲硅烷基)乙基6-O-苯甲酰基-β-D-吡喃半乳糖苷与相应唾液酸的苯基或甲基2-硫代糖苷衍生物进行糖基化反应,得到三种所需的2-(三甲基甲硅烷基)乙基(2S)-唾液酸基-(2→3)-β-吡喃半乳糖苷。这些化合物通过O-苯甲酰化、将2-(三甲基甲硅烷基)乙基选择性转化为乙酰基以及用甲硫基三甲基硅烷将甲硫基引入相应的糖基供体中进行转化。在三氟甲磺酸二甲硫鎓(DMTST)存在下,用这些供体使2-(三甲基甲硅烷基)乙基O-(2,3,4-三-O-苄基-α-L-吡喃岩藻糖基)-(1→3)-O-(2-乙酰氨基-6-O-苄基-2-脱氧-β-D-吡喃葡萄糖基)-(1→3)-2, ,6-三-O-苄基-β-D-吡喃半乳糖苷进行糖基化反应,得到预期的β-糖苷,将其转化为相应的α-三氯乙酰亚胺酯,然后这些酯与(2S, 3R, 4E)-2-叠氮基-3-O-苯甲酰基-4-十八碳烯-1,3-二醇偶联,得到所需的β-糖苷。最后,通过选择性还原叠氮基、与十八烷酸缩合、O-脱酰基和脱酯反应将这些化合物以良好的产率转化为目标化合物。